Senator Bernie Sanders expressed confidence that Novo Nordisk A/S (NYSE:NVO) can be persuaded to reduce the U.S. prices of its popular weight-loss drugs, Ozempic and Wegovy, by publicly ...

The maker of Ozempic and Wegovy was grilled Tuesday by Vermont Sen. Bernie Sanders about U.S. prices far exceeding what Europeans pay.

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite repeatedly being pressed by Sen. Bernie Sanders (I-Vt.), chair of ...

Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

Sen. Sanders claims that the CEOs of major generic drugmakers said they produce and sell Ozempic for less $100 a month.

Sen. Bernie Sanders said he agrees with billionaire Elon Musk that Defense Department spending is too high with little accountability.

Novo Chief Executive Officer Lars Fruergaard Jorgensen is set to be grilled about the drugs’ prices on Tuesday at a hearing led by Vermont Senator Bernie Sanders. The Danish company is facing ...

Sen. Bernie Sanders questions Novo Nordisk CEO Lars Jorgensen in a hearing on Capitol Hill about the high prices Americans pay for Ozempic and Wegovy compared with people in other countries.

WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo Nordisk’s Ozempic and Wegovy if the company lowers the prices of ...

Despite pressure from Bernie Sanders, Novo Nordisk CEO Lars Fruergaard Jørgensen wouldn’t commit to lowering Ozempic and Wegovy prices during a Senate hearing Tuesday.

Sen. Sanders claims that the CEOs of major generic drugmakers said they produce and sell Ozempic for less $100 a month.